Abstract

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser

Author(s): Christiansen Joel, White Lyndell

Issue: Jul/Aug 2010 - Sterile Compounding

Page(s): 310-314

Download in electronic PDF format for $75
  • Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 1
  • Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 2
  • Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 3
  • Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 4
  • Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 5

Abstract

Compounding pharmacists can provide a great therapeutic service to pain management patients who have overcome an addiction to prescribed or illegal drugs or alcohol. By collaborating with the physician and the patient, the compounder can develop an effective analgesic formulation with no addictive potential; a preparation that can be safely adjusted to meet changing medical needs. In this report, we present a personal account of the value of two compounded preparations that relieve severe musculoskeletal pain without producing mood-altering effects, as well as information about how those compounds are prepared.

Related Keywords

  • Joel Christiansen, EdS
  • pain control
  • substance abuse
  • drug addicts
  • addiction recovery
  • analgesic
  • analgesia
  • formulation
  • muscle pain
  • ketoprofen
  • lidocaine
  • cyclobenzaprine hydrochloride
  • topical preparations
  • transdermal administration

Related Categories

  • FORMULATIONS
  • MENTAL HEALTH
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2010
Pg. 310-314
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Author(s): Christiansen Joel, White Lyndell
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 204-206
Managing Pain with Transdermal Ketoprofen
Author(s): Williams KaCee D
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 111-116
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
May/Jun 2009
Pg. 182-190
Update on Managing Neuropathic Pain
Author(s): McNulty Jack P, Muller George
Sep/Oct 2009
Pg. 400-403
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Author(s): Gilbert John A
Nov/Dec 2008
Pg. 498-504
Case Reports: Compounding to Relieve Arthritis Pain
Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
May/Jun 2014
Pg. 182-188
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Author(s): Warner Meredith, Tuder Dmitry
May/Jun 2007
Pg. 202-211
Levorphanol for the Treatment of Severe Chronic Pain
Author(s): McNulty Jack P
May/Jun 2007
Pg. 200
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Author(s): Fields Shannon W
Nov/Dec 2007
Pg. 514-519
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Author(s): Zugerman Jessie Jean M, Reed Thomas C
Nov/Dec 2010
Pg. 514
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 250-256
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Author(s): Trimble John, Light Bob
Jan/Feb 2018
Pg. 19-24
Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Author(s): Shawaqfeh Mohammad S, Harrington Catherine
May/Jun 2007
Pg. 181-184
Transdermal Gel in the Treatment of Postoperative Pain
Author(s): Alexander Kayla, Wynn Tom
Nov/Dec 2010
Pg. 520
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Author(s): Allen Loyd V Jr